Descriptive epidemiology of Parkinson's disease through proxy measures

Daniel Strickland, John M. Bertoni, Ronald F. Pfeiffer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background and Objective: In preparation for analytic study we undertook to describe areas of relative excess and deficit of Parkinson's Disease (PD) in Nebraska and tested two methodologic tools for inexpensive assessment of descriptive epidemiology of PD. Methods: In lieu of large-scale population screening and diagnosis, we obtained sales information of anti-PD drugs in the state in 1988 - 1990 as well as listings of all people dying from 1984 to 1993 who had Parkinson's Disease mentioned anywhere on their death certificate. The anti-PD drug sales data are intended as a proxy far prevalence, while the death certificate data are intended as a proxy for incidence. Results: Sales divided by population over age 54 indicates where anti-PD drug sales differ from expected. We found high correlation of drug sales rates with several farming exposures. Age-adjusted death rates, however, showed a low degree of association with sales or farming variables. This may be attributable to differences in death certificate completion or in underlying incidence versus prevalence. Conclusions: These techniques provide a useful tool for delineating possible differences in incidence and prevalence. While not as accurate as full community survey with expert diagnosis, they are not as expensive, and can be followed by local cluster investigations and individual-level etiologic studies to test hypotheses resulting from the initial study.

Original languageEnglish (US)
Pages (from-to)279-284
Number of pages6
JournalCanadian Journal of Neurological Sciences
Volume23
Issue number4
DOIs
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Proxy
Parkinson Disease
Epidemiology
Death Certificates
Agriculture
Pharmaceutical Preparations
Incidence
Population
Mortality

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Descriptive epidemiology of Parkinson's disease through proxy measures. / Strickland, Daniel; Bertoni, John M.; Pfeiffer, Ronald F.

In: Canadian Journal of Neurological Sciences, Vol. 23, No. 4, 01.01.1996, p. 279-284.

Research output: Contribution to journalArticle

@article{c4e2172295cd44ffb06f2d4d9f94d05b,
title = "Descriptive epidemiology of Parkinson's disease through proxy measures",
abstract = "Background and Objective: In preparation for analytic study we undertook to describe areas of relative excess and deficit of Parkinson's Disease (PD) in Nebraska and tested two methodologic tools for inexpensive assessment of descriptive epidemiology of PD. Methods: In lieu of large-scale population screening and diagnosis, we obtained sales information of anti-PD drugs in the state in 1988 - 1990 as well as listings of all people dying from 1984 to 1993 who had Parkinson's Disease mentioned anywhere on their death certificate. The anti-PD drug sales data are intended as a proxy far prevalence, while the death certificate data are intended as a proxy for incidence. Results: Sales divided by population over age 54 indicates where anti-PD drug sales differ from expected. We found high correlation of drug sales rates with several farming exposures. Age-adjusted death rates, however, showed a low degree of association with sales or farming variables. This may be attributable to differences in death certificate completion or in underlying incidence versus prevalence. Conclusions: These techniques provide a useful tool for delineating possible differences in incidence and prevalence. While not as accurate as full community survey with expert diagnosis, they are not as expensive, and can be followed by local cluster investigations and individual-level etiologic studies to test hypotheses resulting from the initial study.",
author = "Daniel Strickland and Bertoni, {John M.} and Pfeiffer, {Ronald F.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1017/S0317167100038221",
language = "English (US)",
volume = "23",
pages = "279--284",
journal = "Canadian Journal of Neurological Sciences",
issn = "0317-1671",
publisher = "Canadian Journal of Neurological Sciences",
number = "4",

}

TY - JOUR

T1 - Descriptive epidemiology of Parkinson's disease through proxy measures

AU - Strickland, Daniel

AU - Bertoni, John M.

AU - Pfeiffer, Ronald F.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Background and Objective: In preparation for analytic study we undertook to describe areas of relative excess and deficit of Parkinson's Disease (PD) in Nebraska and tested two methodologic tools for inexpensive assessment of descriptive epidemiology of PD. Methods: In lieu of large-scale population screening and diagnosis, we obtained sales information of anti-PD drugs in the state in 1988 - 1990 as well as listings of all people dying from 1984 to 1993 who had Parkinson's Disease mentioned anywhere on their death certificate. The anti-PD drug sales data are intended as a proxy far prevalence, while the death certificate data are intended as a proxy for incidence. Results: Sales divided by population over age 54 indicates where anti-PD drug sales differ from expected. We found high correlation of drug sales rates with several farming exposures. Age-adjusted death rates, however, showed a low degree of association with sales or farming variables. This may be attributable to differences in death certificate completion or in underlying incidence versus prevalence. Conclusions: These techniques provide a useful tool for delineating possible differences in incidence and prevalence. While not as accurate as full community survey with expert diagnosis, they are not as expensive, and can be followed by local cluster investigations and individual-level etiologic studies to test hypotheses resulting from the initial study.

AB - Background and Objective: In preparation for analytic study we undertook to describe areas of relative excess and deficit of Parkinson's Disease (PD) in Nebraska and tested two methodologic tools for inexpensive assessment of descriptive epidemiology of PD. Methods: In lieu of large-scale population screening and diagnosis, we obtained sales information of anti-PD drugs in the state in 1988 - 1990 as well as listings of all people dying from 1984 to 1993 who had Parkinson's Disease mentioned anywhere on their death certificate. The anti-PD drug sales data are intended as a proxy far prevalence, while the death certificate data are intended as a proxy for incidence. Results: Sales divided by population over age 54 indicates where anti-PD drug sales differ from expected. We found high correlation of drug sales rates with several farming exposures. Age-adjusted death rates, however, showed a low degree of association with sales or farming variables. This may be attributable to differences in death certificate completion or in underlying incidence versus prevalence. Conclusions: These techniques provide a useful tool for delineating possible differences in incidence and prevalence. While not as accurate as full community survey with expert diagnosis, they are not as expensive, and can be followed by local cluster investigations and individual-level etiologic studies to test hypotheses resulting from the initial study.

UR - http://www.scopus.com/inward/record.url?scp=0029827615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029827615&partnerID=8YFLogxK

U2 - 10.1017/S0317167100038221

DO - 10.1017/S0317167100038221

M3 - Article

C2 - 8951206

AN - SCOPUS:0029827615

VL - 23

SP - 279

EP - 284

JO - Canadian Journal of Neurological Sciences

JF - Canadian Journal of Neurological Sciences

SN - 0317-1671

IS - 4

ER -